Back to Search
Start Over
Clinical characteristics and prognosis of steroid-resistant nephrotic syndrome in children: a multi-center retrospective study.
- Source :
-
Italian journal of pediatrics [Ital J Pediatr] 2024 Nov 13; Vol. 50 (1), pp. 242. Date of Electronic Publication: 2024 Nov 13. - Publication Year :
- 2024
-
Abstract
- Background: This study investigated the factors influencing the prognosis of children with steroid-resistant nephrotic syndrome (SRNS) in patients from the Guangxi region.<br />Methods: We retrospectively analyzed clinical and pathological data of 279 patients with SRNS from six tertiary hospitals in Guangxi. Clinical data were compared between initial (I-SRNS) and secondary (S-SRNS) steroid resistance subgroups and Cox regression analysis was used to determine risk factors for chronic kidney disease (CKD) and CKD stage 5 (CKD5) in patients with SRNS.<br />Results: The median age of onset was 54 months. Thirty-three patients had extra-kidney manifestations. Fifty-two, 24, 57, 33, and 41 patients had hypertension, acute kidney injury, vitamin D deficiency, high intraocular pressure, and dwarfism, respectively. One hundred eighty-two and 92 patients had I-SRNS and S-SRNS, respectively. There were significant differences in sex, ethnicity, family history, incidence of hematuria, clinical classification, efficacy of immune agents, and prognosis between groups (P < 0.05). Among the 279 cases of SRNS, 239 had normal kidney function, 37 developed CKD, and 16 had CKD5. An increase in serum creatinine level (HR = 1.003) was significantly associated with CKD in children with SRNS, and effective immunosuppressant therapy decreased the CKD risk (HR = 0.168). Patients with increased serum creatinine levels (HR = 1.003) and acute kidney injury (HR = 4.829) were more likely to progress to CKD5.<br />Conclusions: Children with S-SRNS showed a higher response to immunosuppressants than those with I-SRNS. Effective immunosuppressant therapy was found to protect against CKD, whereas increased acute kidney injury was an independent risk factor for CKD5.<br />Competing Interests: Declarations Ethics approval and consent to participate This study was approved by the Ethics Committee for the Evaluation of Clinical Research Projects at the First Affiliated Hospital of Guangxi Medical University, with the approval number 2024-E357-01. Prior to commencing the interview, each participant provided verbal informed consent. All methods were executed in strict adherence to the ethical standards outlined in the 1964 Declaration of Helsinki, including its subsequent amendments. Consent for publication Not applicable. Competing interests All the authors have declared no competing interests.<br /> (© 2024. The Author(s).)
Details
- Language :
- English
- ISSN :
- 1824-7288
- Volume :
- 50
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Italian journal of pediatrics
- Publication Type :
- Academic Journal
- Accession number :
- 39533354
- Full Text :
- https://doi.org/10.1186/s13052-024-01817-4